+987.9%
MRNA vs PTEN
+79.8%
+908.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | PTEN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -9.4% | +22.5% | +11.4% |
| 7D | +20.6% | -15.5% | +36.1% | +17.9% |
| 30D | +27.1% | -7.8% | +34.9% | +26.0% |
| 3M | +353.4% | +6.4% | +347.0% | +353.9% |
| 6M | +446.3% | -11.9% | +458.1% | +458.7% |
| YTD | +776.2% | +79.4% | +696.8% | +571.5% |
| 1Y | +987.9% | +84.9% | +903.0% | +703.2% |
| All | +987.9% | +79.8% | +908.1% | +703.2% |
Cumulative growth
Daily Returns
Daily percentage return beside PTEN.
Daily Out/Under-Performance
Portfolio return minus PTEN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PTEN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded PTEN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling